What’s New

Severe vision loss after orbital surgery appears rare

This retrospective review assessed the risk of severe vision loss after orbital surgery. Source: AAO

Posted on: Jul 16 2018
By: Saratoga Opthalmology
Leave a response

Week in review: Legal hang-up, orange boost, billions and billions

This week, a drop-sized lawsuit is squeezed out of deliberations by the U.S. Supreme Court, an orange a day may keep macular degeneration away and Japan’s Takeda is one step closer to buying Shire for $62 billion. Source: AAO

Posted on: Jul 13 2018
By: Saratoga Opthalmology
Leave a response

Cemiplimab shows promising early outcomes for advanced cutaneous squamous-cell carcinoma

This open-label multicenter study evaluated the human monoclonal antibody, cemiplimab, for treatment of advanced cutaneous squamous-cell carcinoma. Cemiplimab is a high-affinity monoclonal antibody directed against programmed death 1 (PD-1). Source: AAO

Posted on: Jul 13 2018
By: Saratoga Opthalmology
Leave a response

FDA clears AMD monitoring app

Alleye, a mobile medical application developed to monitor progression of patients with AMD, was approved by the FDA earlier this week. Source: AAO

Posted on: Jul 12 2018
By: Saratoga Opthalmology
Leave a response

Are brain MRIs necessary in children with optic nerve hypoplasia?

This retrospective study evaluated the sensitivity and specificity of brain MRI to predict endocrinopathy in children with optic nerve hypoplasia (ONH). Source: AAO

Posted on: Jul 12 2018
By: Saratoga Opthalmology
Leave a response

Lampalizumab fails to prevent geographic atrophy growth

Investigators report data from 2 randomized phase 3 trials assessing the safety and efficacy of lampalizumab, a complement factor D inhibitor, for the treatment of geographic atrophy. Source: AAO

Posted on: Jul 11 2018
By: Saratoga Opthalmology
Leave a response

FDA warning: Do not use sterile drug products from Ranier’s Compounding Laboratory

Due to lack of sterility assurance, the FDA is urging healthcare professionals not to use sterile drug products produced and distributed by Ranier’s Compounding Laboratory, Ranier’s Pharmacy and Ranier’s RX Laboratory, Jeannette, Pennsylvania. Source: AAO

Posted on: Jul 11 2018
By: Saratoga Opthalmology
Leave a response

SMILE induces long-term reduction in posterior astigmatism

This study describes the 3-year changes in anterior and posterior corneal irregular astigmatism and curvature after small incision lenticule extraction. Source: AAO

Posted on: Jul 10 2018
By: Saratoga Opthalmology
Leave a response

High risk of depression in women reporting dry eye symptoms

This cross-sectional study explores whether ocular features of keratoconjunctivitis sicca (KCS) or symptoms of dry eye disease are associated with depression in women with Sjögren syndrome (SS). Source: AAO

Posted on: Jul 9 2018
By: Saratoga Opthalmology
Leave a response

Should patients on isoretinion be excluded from corneal refractive procedures?

In this study, researchers retrospectively assessed functional outcomes when patients underwent corneal refractive procedures while taking the acne drug isotretinoin (Acutane). Source: AAO